登录

生物试剂提供商Teknova推出Build-Tek™解决方案定制配置器和最新AAV-Tek™产品,进一步加速新型疗法的开发

Teknova Launches Proprietary Build-Tek™ Solutions Custom Configurator and Latest AAV-Tek™ Product to Further Accelerate Novel Therapy Development

GlobeNewswire | 2024-05-07 | 翻译由动脉网AI生成,点击反馈

可切换为仅中文


First-of-its-kind custom configurator – available today – gives scientists access to high quality, customizable buffers in small volumes for use in early-stage experiments, all with exceptionally short turnaround times Novel, multi-purpose AAV stabilizer solution increases capsid yield up to 50% while safeguarding product integrity across the AAV purification workflow HOLLISTER, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc.

首创的定制配置器(现已上市)为科学家提供了高质量、可定制的小容量缓冲液,以用于早期实验,所有这些都具有异常短的周转时间。新颖的多用途AAV稳定剂解决方案可将衣壳产量提高至50%,同时在整个AAV净化工作流程中保护产品完整性。加利福尼亚州霍利斯特,2024年5月7日(环球通讯社)——Alpha Teknova,Inc。

(“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today launched the Company’s first custom product configurator, Build-TekTM Solutions, specifically created to address the need for fast turnaround, high-quality buffers for use during early-stage therapy development.

(“Teknova”)(纳斯达克股票代码:TKNO)是用于发现、开发和商业化新型疗法、疫苗和分子诊断的关键试剂的领先制造商,今天推出了该公司的第一个定制产品配置程序Build TekTM Solutions,专为解决早期治疗开发过程中对快速周转、高质量缓冲液的需求而创建。

Teknova also announced the availability of the latest product in their proprietary AAV-TekTM Solutions product line – the AAV-Tek AAV Stabilizer – that substantially improves recovery and protects capsid integrity across the purification workflow. “I’m incredibly proud of our talented team and their unwavering focus on making solutions possible for our customers by addressing critical pain points during therapeutic development,” said Stephen Gunstream, President and Chief Executive Officer.

Teknova还宣布其专有的AAV-TekTM解决方案产品线中提供了最新产品-AAV-Tek AAV稳定剂,该产品可在整个纯化工作流程中大大提高回收率并保护衣壳完整性。总裁兼首席执行官斯蒂芬·冈斯特劳(StephenGunstream)表示:“我为我们的天才团队感到无比骄傲,他们坚定不移地致力于通过解决治疗开发过程中的关键痛点,为客户提供解决方案。”。

“With the launch of Build-Tek Solutions, we’re now able to support research scientists with small volumes of multiple discrete buffer formulations that are made from high-quality raw materials and QC tested. Our custom configurator is easy to use, and by leveraging our modular manufacturing platform, products ship in a matter of days.

“随着Build-Tek解决方案的推出,我们现在能够为研究科学家提供少量由高质量原材料制成的多个离散缓冲液配方,并经过QC测试。我们的定制配置器易于使用,并且通过利用我们的模块化制造平台,产品可以在几天内发货。

Now scientists can focus on advancing science by getting reproducible, trusted results during their early-stage experiments i.

现在,科学家可以通过在早期实验i中获得可重复的,可信的结果来专注于推进科学。

推荐阅读

Alpha Teknova在推出AAV Tek AEX AAV6缓冲筛选套件时上涨43%

RTTNews 2023-09-27 22:13

年入1222亿,雅培医疗器械

思宇MedTech 2024-05-20 00:15

新的2a期临床试验结果证明Endeavor BioMedicines的ENV-101改善了特发性肺纤维化患者的肺功能并逆转了肺纤维化的关键措施

businesswire 2024-05-20 00:12

GlobeNewswire

8168篇

最近内容 查看更多

Dyne Therapeutics将于美国东部时间明天5月20日上午8:00举办虚拟投资者活动,审查ACHIEVE和DELIVER试验的新临床数据

24 分钟后

NASDAQ:NARI:Kessler Topaz Meltzer&Check,LLP通知投资者对Inari Medical,股份有限公司提起的证券集体诉讼

21 小时前

Intercept提供了新数据,证明OCA-苯扎贝特联合治疗对2024年消化道疾病周治疗六个月后ALP和代谢结果的影响

1 天前

相关公司查看更多

Alpha Teknova

生物试剂提供商

立即沟通

产业链接查看更多

所属赛道

生物制品-疫苗